CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation

A Pupovac1, L Stokes, R Sluyter

  • 1School of Biological Sciences, University of Wollongong, Wollongong, NSW, Australia.

Purinergic Signalling
|June 25, 2013
PubMed

Insights

The P2X7 receptor antagonist CAY10593 inhibits ATP-induced pore formation, independent of phospholipase D1 (PLD1). This finding is crucial for understanding P2X7 receptor signaling and drug development.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • The P2X7 receptor is a critical ATP-gated ion channel involved in numerous physiological and pathological processes.
  • Previous studies indicated that the phospholipase D1 (PLD1) antagonist CAY10593 affects P2X7 receptor-mediated CD23 shedding.

Purpose of the Study:

  • To elucidate the mechanism of action of CAY10593 on P2X7 receptor activation.
  • To determine if CAY10593's effects on P2X7 are mediated through PLD1 inhibition.

Main Methods:

  • ATP-induced ethidium(+) uptake assays were performed in various cell types (RPMI 8226, HEK-293, PBMCs).
  • Concentration-response curves were generated for CAY10593, CAY10594, and halopemide.
  • Electrophysiology was used to measure P2X7-induced currents.
  • RT-PCR was employed to assess PLD1 expression.

Main Results:

  • CAY10593 significantly impaired P2X7-induced pore formation and inward currents in human cells.
  • The inhibitory effect of CAY10593 on P2X7 was more potent than other PLD antagonists.
  • PLD1 was found to be absent in RPMI 8226 cells, and PLD inhibition did not affect P2X7 activation.

Conclusions:

  • CAY10593 inhibits human P2X7 receptor function independently of PLD1.
  • This study underscores the necessity of validating that signaling modulators do not directly impact the target receptor, such as P2X7.
  • Findings provide critical insights into P2X7 receptor pharmacology and potential off-target effects of antagonists.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...